About Amani Therapeutics
Amani Therapeutics is a private company based in New York, New York, incorporated in 2025 in Delaware. It has reported $66,119,999 raised in two offerings on Form D since December 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Oct 1, 2026 | $34,999,999of $59.9M target | 5 | $6.9M | EquityRule 506(b) | Form D ↗ |
| Nov 25, 2025 | Dec 10, 2025 | $31,120,000fully sold | 2 | $15.5M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $66,119,999 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Amani Therapeutics's Form D filed Oct 1, 2026.
AL
Alice Lee
Executive officer
RL
-- RTW Holdings VI, LLC
Promoter
LC
Lauren Cuje
Director
PF
CW
Connor Williams
Director